Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:524867818:1859 |
Source | marc_columbia |
Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:524867818:1859?format=raw |
LEADER: 01859fam a2200421 a 4500
001 3966440
005 20221027011330.0
008 920320t19921992mdua b 001 0 eng c
010 $a 92005759
020 $a0683002546
035 $a(OCoLC)25554577
035 $a(OCoLC)ocm25554577
035 $9AGD2047HS
035 $a(NNC)3966440
035 $a3966440
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC271.C5$bH54 1992
060 0 $aQZ 267 H638
082 00 $a616.99/4061$220
245 00 $aHigh-dose cancer therapy :$bpharmacology, hematopoietins, stem cells /$cedited by James O. Armitage, Karen H. Antman.
260 $aBaltimore :$bWilliams & Wilkins,$c[1992], ©1992.
300 $axxi, 816 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
650 0 $aCancer$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh85019497
650 0 $aCancer$xChemotherapy$xComplications$xPrevention.
650 0 $aDrugs$xDosage.$0http://id.loc.gov/authorities/subjects/sh85039725
650 0 $aHematopoietic growth factors$xTherapeutic use.
650 0 $aBone marrow$xEffect of drugs on.
650 2 $aAntineoplastic Agents$xadministration & dosage.$0https://id.nlm.nih.gov/mesh/D000970Q000008
650 2 $aDose-Response Relationship, Drug.$0https://id.nlm.nih.gov/mesh/D004305
650 2 $aHematopoietic Cell Growth Factors$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D016298Q000627
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
700 1 $aArmitage, James O.,$d1946-$0http://id.loc.gov/authorities/names/n92801229
700 1 $aAntman, Karen.$0http://id.loc.gov/authorities/names/n85324685
740 0 $aHigh dose cancer therapy.
852 00 $boff,hsl$hRC271.C5$iH54 1992